Strains of S. pneumoniae are characterized by a high diversity
of serotypes (more than 90 serotypes have been described so
far), and so vaccines are effective only against those serotypes
whose polysaccharides are included in the formulation. Due to
the multidrug resistance of the S. pneumoniae pathogen and
the different geographic distributions of its serotypes, many
studies are being conducted to develop effective formulations